2236 PSA NADIR AS A PROGNOSTIC INDICATOR OF BIOCHEMICAL PROGRESSION FREE SURVIVAL AFTER PRIMARY WHOLE GLAND CRYOABLATION OF THE PROSTATE

Ahmed Elshafei,Yonghong Li,Nirmal Krishnan,Asmaa Hatem,David Levy,J. Stephen Jones

DOI: https://doi.org/10.1016/j.juro.2013.02.2145

2013-01-01

Abstract:You have accessJournal of UrologyProstate Cancer: Markers (II)1 Apr 20132236 PSA NADIR AS A PROGNOSTIC INDICATOR OF BIOCHEMICAL PROGRESSION FREE SURVIVAL AFTER PRIMARY WHOLE GLAND CRYOABLATION OF THE PROSTATE Ahmed Elshafei, Yonghong Li, Nirmal Krishnan, Asmaa Hatem, David Levy, and J.Stephen Jones Ahmed ElshafeiAhmed Elshafei Cleveland, OH More articles by this author , Yonghong LiYonghong Li Cleveland, OH More articles by this author , Nirmal KrishnanNirmal Krishnan Cleveland, OH More articles by this author , Asmaa HatemAsmaa Hatem Cleveland, OH More articles by this author , David LevyDavid Levy Cleveland, OH More articles by this author , and J.Stephen JonesJ.Stephen Jones Cleveland, OH More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.02.2145AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Our aim is to identify prognostic value of Prostate Specific Antigen (PSA) nadir after primary whole gland prostate cryoablation on biochemical progression free survival (bPFS). METHODS We analyzed 158 patients from an IRB approved database who underwent primary whole gland cryoablation at our institute. We identified pre-operative variables including patient age, race, initial PSA, prostate gland volume, Gleason score, maximum cancer percentage per core, percentage of positive cores in relation to total number of cores, percentage of positive cores in relation to total gland volume & bPFS. We identified post-operative findings such as PSA nadir, bPFS stratified by the D'Amico criteria using the Phoenix definition. RESULTS Our analysis showed that patients with PSA nadir of < 0.40 ng/ml had a bPFS of 92% compared to 50% in patients with PSA nadir ≥0.40 ng /ml with mean follow up time of 29 months .Moreover, bPFS based on D'Amico risk stratification in patients with PSA nadir <0.40 ng/ml had a 100%, 89% & 84% with low, intermediate & high risk criteria respectively. Patients who failed to reach PSA nadir < 0.40 ng/ml had 66.6%,55.5% & 28.5% with low, intermediate & high risk criteria respectively (table 1). Descriptive analysis of preoperative prognostic factors between the two groups of PSA nadir <0.40 ng/ml & ≥ 0.40 ng/ml demonstrated that the only significant factor is the presence of high PSA at time of diagnosis (P=0.03). (Table 2) CONCLUSIONS Based on our data, PSA nadir <0.40 after primary whole gland cryoablation of the prostate is associated with very favorable biochemical progression free survival and should be the treatment goal. Table 1. PSA Nadirs and Success Rates after Primary Whole Gland Cryoablation Nadir PSA Range (ng/ml) Total Number of Patients (n=158) Low Risk Intermediate Risk High Risk Total Success Rate < 0.4 136 100% (n=44) 89% (n=73) 84% (n=19) 92% ≥0.4 22 66.6% (n=6) 55.5% (n=9) 28.5% (n=7) 50% Table 2. Descriptive analysis of patients dichotomized by a PSA Nadir of 0.40ng/mL Cohort Variable (n=158) PSA < 0.4 ng/mL (n=136) PSA≥0.4ng/mL (n=22) P-Value Age (median-range) 68 (64-74) 69 (65-76) 0.5 Race (White/African-American/Others) 112/9/15 15/4/3 0.2 PSA at time of diagnosis (median-range) 5.2 (4-7) 6.5 (5-11) 0.03 Volume (median-range) 31 (26-42) 30 (23-35.8) 0.2 Gleason score ≥7 64.7% 72.7% 0.46 Maximum cancer perecnt(median-range) 40 (15-63) 50 (10-85) 0.5 % of positive cores (median-range) 21 (8.3-41.6) 29 (12.7-52) 0.5 % of positive cores/total volume (median-range) 8.6 (4.5-17.4) 14.7 (4.3-23.4) 0.2 © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 189Issue 4SApril 2013Page: e917 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.MetricsAuthor Information Ahmed Elshafei Cleveland, OH More articles by this author Yonghong Li Cleveland, OH More articles by this author Nirmal Krishnan Cleveland, OH More articles by this author Asmaa Hatem Cleveland, OH More articles by this author David Levy Cleveland, OH More articles by this author J.Stephen Jones Cleveland, OH More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...